Pros and cons of different therapeutic antibody formats for recombinant antivenom development

por Laustsen, Andreas Hougaard, Gutiérrez, José María, Knudsen, Cecilie, Johansen, Kristoffer H., Bermúdez Méndez, Erick, Cerni, Felipe A., Jürgensen, Jonas A., Ledsgaard, Line, Martos Esteban, Andrea, Øhlenschlæger, Mia, Pus, Urska, Andersen, Mikael Rørdam, Lomonte, Bruno, Engmark, Mikael Gerling, Pucca, Manuela Berto
Publicado 2019